Profit

Pfizer mulls buying Strides Arcolab's Agila Specialties - report

 Share
EMAIL
PRINT
COMMENTS
Pfizer mulls buying Strides Arcolab's Agila Specialties - report
New York: 
Comments
Pfizer is considering buying India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab, for a possible price of $2 billion (Rs 10,886.31 crore), Bloomberg reported on Monday.

Pfizer is doing due diligence and a deal could be reached this quarter, Bloomberg reported, citing unnamed sources.

A Pfizer spokeswoman said the company does not comment on market rumours or speculation.

Agila makes cancer treatments and antibiotics, Bloomberg said.

Copyright @ Thomson Reuters 2013


NDTV Beeps - your daily newsletter

................................ Advertisement ................................

................................ Advertisement ................................